ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-11Q13104
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global ICAD Intracranial Atherosclerotic Disease Pathology Market Research Report 2023
BUY CHAPTERS

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-11Q13104
Report
June 2025
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Stryker
Balt
Terumo
MicroPort
Acandis GmbH

ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size

Pathology was estimated to be worth US$ 206 million and is forecast to reach approximately US$ 368 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.

ICAD (Intracranial Atherosclerotic Disease) Pathology Market

ICAD (Intracranial Atherosclerotic Disease) Pathology Market

In 2024, the global market size of ICAD (Intracranial Atherosclerotic Disease)
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICAD (Intracranial Atherosclerotic Disease) Pathology.
The ICAD (Intracranial Atherosclerotic Disease) Pathology market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global ICAD (Intracranial Atherosclerotic Disease) Pathology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology Market Report

Report Metric Details
Report Name ICAD (Intracranial Atherosclerotic Disease) Pathology Market
Forecasted market size in 2031 approximately US$ 368 million
CAGR 8.8%
Forecasted years 2025 - 2031
Segment by Type
  • Stent
  • PTA Balloon
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Stryker, Balt, TERUMO, MicroPort, Acandis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ICAD (Intracranial Atherosclerotic Disease) Pathology sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the ICAD (Intracranial Atherosclerotic Disease) Pathology Market size in 2031?

Ans: The ICAD (Intracranial Atherosclerotic Disease) Pathology Market size in 2031 will be approximately US$ 368 million.

What is the market share of major companies in ICAD (Intracranial Atherosclerotic Disease) Pathology Market?

Ans: Global top five manufacturers hold a share about 90%.

What is the ICAD (Intracranial Atherosclerotic Disease) Pathology Market share by type?

Ans: In terms of product, Stent is the largest segment, with a share about 80%.

Who are the main players in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market report?

Ans: The main players in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market are Stryker, Balt, TERUMO, MicroPort, Acandis

What are the Application segmentation covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market report?

Ans: The Applications covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market report?

Ans: The Types covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market report are Stent, PTA Balloon

Recommended Reports

Neurovascular Devices

Vascular Intervention

Stroke & Therapy

1 Study Coverage
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
1.2 Market by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market by Application
1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Estimates and Forecasts
2.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2020-2031
2.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2020-2031
2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region: 2024 Versus 2031
2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2020-2031)
2.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2020-2025
2.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Region (2026-2031)
2.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2020-2031)
2.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Projections by Region (2026-2031)
2.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region: 2020-2025
2.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Region (2026-2031)
2.4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2031)
3.1.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Type (2020-2031)
3.1.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2020-2031)
3.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2020-2031)
3.1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2020-2031)
3.1.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2020-2031)
3.1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2031)
3.2.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Application (2020-2031)
3.2.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2020-2031)
3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2020-2031)
3.2.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2020-2031)
3.2.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2020-2031)
3.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Stent of ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application
3.3.2 PTA Balloon of ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application
4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Manufacturers
4.1 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers by Sales (2020-2025)
4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturer (2020-2025)
4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers by Revenue (2020-2025)
4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturer (2020-2025)
4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturer (2020-2025)
4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Covered: Ranking by Revenue
4.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution, Product Type
4.5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market
4.5.3 Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type and Application
4.5.4 Stent Market Sales of ICAD (Intracranial Atherosclerotic Disease) Pathology by Manufacturer
4.5.5 PTA Balloon Market Sales of ICAD (Intracranial Atherosclerotic Disease) Pathology by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Stryker
5.1.1 Stryker Company Information
5.1.2 Stryker Description, Business Overview
5.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
5.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product in 2024
5.1.6 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application in 2024
5.1.7 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Geographic Area in 2024
5.1.8 Stryker Recent Developments
5.2 Balt
5.2.1 Balt Company Information
5.2.2 Balt Description, Business Overview
5.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
5.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product in 2024
5.2.6 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application in 2024
5.2.7 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Geographic Area in 2024
5.2.8 Balt Recent Developments
5.3 TERUMO
5.3.1 TERUMO Company Information
5.3.2 TERUMO Description, Business Overview
5.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
5.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2020-2025)
5.3.5 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product in 2024
5.3.6 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application in 2024
5.3.7 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Geographic Area in 2024
5.3.8 TERUMO Recent Developments
5.4 MicroPort
5.4.1 MicroPort Company Information
5.4.2 MicroPort Description, Business Overview
5.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
5.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2020-2025)
5.4.5 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product in 2024
5.4.6 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application in 2024
5.4.7 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Geographic Area in 2024
5.4.8 MicroPort Recent Developments
5.5 Acandis
5.5.1 Acandis Company Information
5.5.2 Acandis Description, Business Overview
5.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
5.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product in 2024
5.5.6 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application in 2024
5.5.7 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Geographic Area in 2024
5.5.8 Acandis Recent Developments
6 North America
6.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2020-2031
6.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
6.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2020-2031)
6.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2020-2031)
6.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025)
6.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2020-2031
7.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Region
7.2.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2020-2031)
7.2.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2020-2031)
7.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025)
7.4 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025)
8 Europe
8.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2020-2031
8.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
8.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2020-2031)
8.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2020-2031)
8.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025)
8.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025)
9 Latin America
9.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2020-2031
9.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
9.2.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2020-2031)
9.2.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2020-2031)
9.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025)
9.4 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2020-2031
10.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
10.2.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2020-2031)
10.2.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2020-2031)
10.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025)
10.4 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Supply Chain Analysis
11.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials and Upstream Suppliers
11.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Clients Analysis
11.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Channel and Sales Model Analysis
11.4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
12 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Dynamics
12.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
12.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
12.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Stryker
Balt
Terumo
MicroPort
Acandis GmbH
List of Tables
 Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2020-2025) & (Units)
 Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Region (2026-2031) & (Units)
 Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Type (2020-2025) & (Units)
 Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Type (2026-2031) & (Units)
 Table 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Application (2020-2025) & (Units)
 Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Application (2026-2031) & (Units)
 Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturer (2020-2025) & (Units)
 Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Manufacturer (2020-2025)
 Table 18. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2024)
 Table 24. ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market
 Table 26. Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Stryker Company Information
 Table 29. Stryker Description and Business Overview
 Table 30. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
 Table 31. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Stryker Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Product in 2024
 Table 33. Stryker Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application in 2024
 Table 34. Stryker Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Geographic Area in 2024
 Table 35. Stryker Recent Developments
 Table 36. Balt Company Information
 Table 37. Balt Description and Business Overview
 Table 38. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product
 Table 39. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Balt Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Product in 2024
 Table 41. Balt Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application in 2024
 Table 42. Balt Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Geographic Area in 2024
 Table 43. Balt Recent Developments
 Table 44. TERUMO Company Information
 Table 45. TERUMO Description and Business Overview
 Table 46. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product
 Table 47. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. TERUMO Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Product in 2024
 Table 49. TERUMO Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application in 2024
 Table 50. TERUMO Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Geographic Area in 2024
 Table 51. TERUMO Recent Developments
 Table 52. MicroPort Company Information
 Table 53. MicroPort Description and Business Overview
 Table 54. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product
 Table 55. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. MicroPort Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Product in 2024
 Table 57. MicroPort Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application in 2024
 Table 58. MicroPort Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Geographic Area in 2024
 Table 59. MicroPort Recent Developments
 Table 60. Acandis Company Information
 Table 61. Acandis Description and Business Overview
 Table 62. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product
 Table 63. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Acandis Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Product in 2024
 Table 65. Acandis Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application in 2024
 Table 66. Acandis Sales Proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology by Geographic Area in 2024
 Table 67. Acandis Recent Developments
 Table 68. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2020-2025) & (Units)
 Table 69. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2026-2031) & (Units)
 Table 70. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2020-2025) & (US$ Million)
 Table 71. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2026-2031) & (US$ Million)
 Table 72. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025) & (Units)
 Table 73. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025) & (Units)
 Table 74. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2020-2025) & (Units)
 Table 75. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2026-2031) & (Units)
 Table 76. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2020-2025) & (US$ Million)
 Table 77. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2026-2031) & (US$ Million)
 Table 78. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025) & (Units)
 Table 79. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025) & (Units)
 Table 80. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2020-2025) & (Units)
 Table 81. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2026-2031) & (Units)
 Table 82. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2020-2025) & (US$ Million)
 Table 83. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2026-2031) & (US$ Million)
 Table 84. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025) & (Units)
 Table 85. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025) & (Units)
 Table 86. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2020-2025) & (Units)
 Table 87. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2026-2031) & (Units)
 Table 88. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2020-2025) & (US$ Million)
 Table 89. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2026-2031) & (US$ Million)
 Table 90. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025) & (Units)
 Table 91. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025) & (Units)
 Table 92. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2020-2025) & (Units)
 Table 93. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2026-2031) & (Units)
 Table 94. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2020-2025) & (US$ Million)
 Table 95. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2026-2031) & (US$ Million)
 Table 96. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025) & (Units)
 Table 97. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025) & (Units)
 Table 98. ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials, Industry Status and Trend
 Table 99. ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials and Upstream Suppliers
 Table 100. ICAD (Intracranial Atherosclerotic Disease) Pathology Clients Status and Trend
 Table 101. ICAD (Intracranial Atherosclerotic Disease) Pathology Typical Clients
 Table 102. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
 Table 103. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Trends
 Table 104. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
 Table 105. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
 Table 106. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Picture
 Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2024 & 2031
 Figure 4. Stent Product Picture
 Figure 5. PTA Balloon Product Picture
 Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application in 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered
 Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size 2020-2031 (US$ Million)
 Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2020-2031 (Units)
 Figure 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2020-2031)
 Figure 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 23. Stent of ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application, 2024 VS 2031
 Figure 24. PTA Balloon of ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Manufacturer in 2024
 Figure 26. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Stent Market Sales Proportion by Manufacturer in 2024
 Figure 28. PTA Balloon Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2020-2031 (US$ Million)
 Figure 30. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2020-2025)
 Figure 31. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2020-2025)
 Figure 37. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2020-2031)
 Figure 39. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2020-2031)
 Figure 40. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2020-2025)
 Figure 41. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2020-2025)
 Figure 42. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2020-2031)
 Figure 44. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2020-2025)
 Figure 46. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2020-2025)
 Figure 52. ICAD (Intracranial Atherosclerotic Disease) Pathology Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology Raw Materials by Region in 2024
 Figure 54. ICAD (Intracranial Atherosclerotic Disease) Pathology Distribution Channels
 Figure 55. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

ICAD Intracranial Atherosclerotic Disease Pathology Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intracranial Atherosclerotic Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intracranial Aneurysm Treatment Market Insights Forecast to 2030
Intracranial Stent System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intracranial Stents Market Research Report 2025
Global Balloon expanded Intracranial Stents Market Research Report 2024
Global Atherosclerosis Therapeutics Market Insights Forecast to 2030
Global Cerebrovascular Disease Market Research Report 2024
Global Self expandable Intracranial Stents Market Research Report 2024
Global Ischemic Neurointerventional Device Market Research Report 2025
Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Research Report 2024
Global AI Medical Imaging Software for Chronic Cerebrovascular Diseases Market Research Report 2024
Global Cerebral Infarction Therapy Market Insights Forecast to 2030
Ischemic Cerebrovascular Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coronary Artery Disease Therapeutics Market Research Report 2024
Brain Ischemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cerebral Aneurysm Covered Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intrasaccular Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peripheral Artery Disease Treatment Devices Market Research Report 2024
Global Coronary Artery Imaging Market Research Report 2024

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions